Literature DB >> 18191479

Long-term trends (1986-2003) in the use of coronary reperfusion strategies in patients hospitalized with acute myocardial infarction in central Massachusetts.

Robert J Goldberg1, Frederick A Spencer, Joseph Okolo, Darleen Lessard, Jorge Yarzebski, Joel M Gore.   

Abstract

BACKGROUND: The objectives of our study were to examine long-term (1986-2003) trends in the use of percutaneous coronary interventions (PCI) and thrombolytic therapy in the management of patients hospitalized at all Central Massachusetts medical centers with acute myocardial infarction (AMI). Our secondary study goal was to examine factors associated with use of these coronary reperfusion strategies. Limited contemporary data are available about changing trends in the use of coronary reperfusion strategies, particularly from a population-based perspective.
METHODS: The sample consisted of 9422 greater Worcester (MA) residents hospitalized with AMI at all metropolitan Worcester medical centers in 10 annual periods between 1986 and 2003.
RESULTS: Divergent trends in the use of PCI and thrombolytic therapy during hospitalization for AMI were noted. Use of thrombolytic therapy increased after its introduction to clinical practice in the mid-1980s through the early 1990s with a progressive decline in use thereafter. In 2003, 3.5% of patients hospitalized with AMI were treated with clot lysing therapy. Marked increases in the use of PCI during hospitalization for AMI were noted over time. In 2003, 42.1% of patients with AMI received a PCI. Several demographic and clinical factors were associated with the use of these different treatment strategies.
CONCLUSIONS: The results of our study in a large New England (United States) community suggest evolving changes in the hospital management of patients with AMI. Current management practices emphasize the utilization of PCI to restore coronary reperfusion to the infarct related artery.

Entities:  

Mesh:

Year:  2008        PMID: 18191479      PMCID: PMC2615539          DOI: 10.1016/j.ijcard.2007.10.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  20 in total

1.  Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).

Authors:  Kim A Eagle; Shaun G Goodman; Alvaro Avezum; Andrzej Budaj; Cynthia M Sullivan; José López-Sendón
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

2.  A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).

Authors:  D Hasdai; S Behar; L Wallentin; N Danchin; A K Gitt; E Boersma; P M Fioretti; M L Simoons; A Battler
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

3.  Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey.

Authors:  P G McGovern; D R Jacobs; E Shahar; D K Arnett; A R Folsom; H Blackburn; R V Luepker
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

4.  Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry.

Authors:  R Zahn; R Schiele; S Schneider; A K Gitt; H Wienbergen; K Seidl; T Voigtländer; M Gottwik; G Berg; E Altmann; W Rosahl; J Senges
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

5.  The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment.

Authors:  K A Fox; D V Cokkinos; J Deckers; U Keil; A Maggioni; G Steg
Journal:  Eur Heart J       Date:  2000-09       Impact factor: 29.983

6.  Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective.

Authors:  F Spencer; G Scleparis; R J Goldberg; J Yarzebski; D Lessard; J M Gore
Journal:  Am Heart J       Date:  2001-10       Impact factor: 4.749

7.  A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study).

Authors:  Robert J Goldberg; Frederick A Spencer; Jorge Yarzebski; Darleen Lessard; Joel M Gore; Joseph S Alpert; James E Dalen
Journal:  Am J Cardiol       Date:  2004-12-01       Impact factor: 2.778

Review 8.  New frontiers and unresolved controversies in percutaneous coronary intervention.

Authors:  Vladimir Dzavik
Journal:  Am J Cardiol       Date:  2003-02-06       Impact factor: 2.778

Review 9.  Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Venu Menon; Robert A Harrington; Judith S Hochman; Christopher P Cannon; Shaun D Goodman; Robert G Wilcox; Holger J Schünemann; E Magnus Ohman
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

10.  Regional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantage.

Authors:  Harlan M Krumholz; Jersey Chen; Saif S Rathore; Yun Wang; Martha J Radford
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

View more
  1 in total

1.  Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.

Authors:  David D McManus; Joel Gore; Jorge Yarzebski; Frederick Spencer; Darleen Lessard; Robert J Goldberg
Journal:  Am J Med       Date:  2011-01       Impact factor: 4.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.